Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo-Controlled Trial

Table 2

Procedures of the trial.

Item	Baseline	week	week	week	2 week	5 week	7 week	10 week
Eligibility screening	√
Signed inform consent	√
Spleen Qi Deficiency Symptoms Grading and Quantifying Scale	√	√	√	√	√	√	√	√
Physical examination (height, weight, blood pressure, heart rate)	√	√	√	√	√	√	√	√
Blood, urine, and stool routine examination	√			√	√	√	√	√
Electrocardiogram	√			√	√	√	√	√
Liver function (ALT, AST, TBIL, DBIL, IBIL)	√			√	√	√	√	√
Kidney function (Scr, BUN)	√			√	√	√	√	√
Gastric function (Gastrin-17)	√					√		√
Helicobacter Pylori	√
Gastroscopy	√							√
Record of adverse events				√	√	√	√	√
Compliance assessment		√	√	√	√	√	√	√

ALT = alanine transaminase, AST = aspartate aminotransferase, TBIL = total bilirubin, DBIL = direct bilirubin, IBIL = indirect bilirubin, SCr = serum creatinine, BUN = urea nitrogen, and PT= prothrombin time.